CellProtect Nordic Pharmaceuticals AB participates in the SWElife’s project on Advanced Therapy Medicinal Products (ATMPs)

CellProtect Nordic Pharmaceuticals AB  participates in the SWElife’s project on Advanced Therapy Medicinal Products (ATMPs)

SWElife’sATMP project focuses on business development based on health economics, value-based health care and the available infrastructures within Sweden. The goal is to strengthen Sweden’s position in the international field of ATMPs.

CellProtect Nordic Pharmaceuticals AB  is one of 14 project partners representing both academia and public bodies as well as the private sector. The partners will contribute with their expertise to pave the way for these pharmaceuticals to the patient’s bedside.

Karin Mellström will represent CellProtect Nordic Pharmaceuticals AB  in the coming discussions.

“We are very happy to participate in this work that may have a significant impact on patients with severe, currently incurable, diseases”  says Karin Mellström, CEO of CellProtect Nordic Pharmaceuticals AB 

 Read more about the project on SWElife homepage (Swedish): 

https://swelife.se/2018/11/13/nytt-projekt-greppar-om-de-avancerade-terapilakemedlens-halsoekonomiska-utmaningar/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s